DOCSLIB.ORG

Primary Antibodies & Antigens Introduction

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Primary Antibodies & Antigens Introduction Introduction Primary Antibodies & Antigens Interchim provides more than 20 000 primary antibodies and all secondary and accessory reagents to perform your immunodetections in ELISA, Blotting, FCM or microscopy techniques. This includes our high quality secondary antibodies labeled (HRP, Alkaline Phosphatase, Biotin) ! our great FluoProbes® dyes ! Fluograde microplates (FPlyte) ! Ultimate sensitivity HRP substrates (TMB plus) ! Remarkable saturating agents (Seablock) ! Some powerful instruments (fluorescence LED microscope) Immunologicals A.1 e-mail [email protected] ! Visit our website : www.interchim.com Primary Antibodies & Antigens Introduction Some History... The use of primary antibodies (I Abs) as research tools is, in many ways, responsible One of the earliest use for antibodies, came in the for much of the progress seen in modern biological research. These antibodies, early part of the 20th Century when Karl specific of target antigens, are a first step to probe samples in various detections. Landsteiner developped a serological test for They can also be used to immobilize antigens on supports. Secondary antibodies (II different blood groups (ABO system for typing Abs) are used in a second step to detect and amplify I Abs signal by colour or light blood) identification. Today antibodies are used as versatile reagents for an extremely wide range emission as fluorescence or chemiluminescence. of assays, in techniques as varied as screening phage libraries, biosensors, affinity purifications, Interchim is proud to offer one of the largest choice of high quality primary antibodies and conventional immunoassays including (more than 20 000 items). ELISA, blotting, flow cytometry, agglutinations... Because of these multiple uses, a wide range of To make your search easier among this huge list, we propose two different ways of antibodies is needed (regarding to antigen- classification: specificity, binding affinity, and format/purity). Fortunately, a large number of companies now provide antibodies for researchers. This means ! Research Interests that each individual lab no longer has to go through 24 research areas are listed and shortly presented hereafter. Each area lists the hassle of generating, purifying and testing key words (specificities) that can be searched in the antibody alphabetical their own antibodies. However it is often difficult listing. A detailed description of some key related antibodies is inserted in the to find out the antibody companies, and the best alphabetical listing of antibodies. supplier. ! Alphabetical Listing This list presents our antibodies by specifity in alphanumerical order of specificities. It displays key informations : species cross reactivity, host, quantity, compatible immunotechniques and identified related research areas. Please refer to the legend for codified information. ! A third part is dedicated to last minute Antibodies. It includes Chicken IgY antibodies and mitochondrial research antibodies. ! In a fourth part, you will find an alphabetical listing of our mayor antigens and bioactive peptides (more than 4000). The research areas corresponding to these antigens are also displayed in the table with the same codification (1-24) as for antibodies. Do not hesitate to contact us if you do not find the requested specificity or if you need further details. Immunologicals This catalog cannot be exhaustive, while our web site Thanks to : is continuously updated with new antibodies. Please ! its huge database search on our web site http://www.interchim.com/ ! its excellent technical support interchim/customers/. With our e-search tool, you can ! and its ability to provide all associated products (secondary, substrate, kits…) search by name, key words with Booleans, INTERCHIM number as well as supplier catalog number, and obtain all ordering information. Interchim is your reliable supplier for primary antibodies. A.2 We can also source any Abs for you, thanks to our If the antibody you are looking for is not available on the market, keep in mind our access to large databases and experienced custom services : relationships with most of world Abs suppliers! Custom Rabbit AND Mouse polyclonal, as well as Mouse Monoclonal. Tel 33 (0)4 70 03 88 55 !! Hot line 33 (0)4 70 03 73 06 Fax 33 (0)4 70 03 82 60 Primary Antibodies & Antigens Primary antibodies by Research Interest Hereafter are described the 24 areas for antibody classification by Research Interest. After a small description, a list of our related antibodies is displayed. More information on the antibodies can be found in the Alphabetical classification table. 1 - Allergens Have a look at Chapter F, page 3 for a list of our An allergen is a substance that causes an acute defensive reaction in a person’s food allergens detection kits. immune system. Brazil nut Histamine Brazilian Scampi Histamine Receptor 1-4 Casein alpha Lobster protein Cashew nut Shrimp protein Crab Soy protein Egg 2 - Angio / Histogenesis Histogenesis is the process of tissue formation while Angiogenesis is the formation of new blood vessels from existing vasculature. These processes are implicated in tumor growth and metastasis. Activin Receptor Type II CD61 / GPIIIa Flk-1 / VEGFR-2 Raf-1 Angiogenin CD62E Flt-1 / VEGFR-1 Thomsen-Friedenreich Antigen Angiopoietin 1-4 CD105 / Endoglin Heparan Sulfate Proteoglycan Thrombospondin BAI 1-3 CD106 / VCAM-1 HIF-1a, b, 2a Thymidine Phosphorylase BMP 1-15 CD141 / Thrombomodulin HLA Antigens Transglutaminase C Immunologicals CD29 COL1A1, C-term HLTF Transglutaminase II CD31 / PECAM-1 Elastase, neutrophil Kringles Urokinase Plasminogen activator CD34 Endothelial Marker L1 Cell Adhesion Molecule VEGF CD36 GPIIIb / GPIV Factor VIII Related Antigen Microglobulin beta 2-3 CD41 Factor XIIIa Plasminogen CD41a FAK Plasminogen Activator Inhibitor 1-2 A.3 e-mail [email protected] ! Visit our website : www.interchim.com Primary Antibodies & Antigens Primary antibodies by Research Interest 3 - Apoptosis / cell cycle Apoptosis : Also known as programmed cell death, apoptosis is the process in which abnormal cells are eliminated and prevented from further cell divisions. Have a look at Chapter E for more details on Cell Cycle : Cell division. A complete cell cycle consists of the G1, S, G2 and M phases. Apoptosis and Cell Cycle and for a list of our In mitosis a single cell gives 2 identical daughter cells, while in meiosis a single cell related kits. gives raise to 4 haploid cells. 14-3-3 gamma C-Jun JunB, JunD PERP 8-oxo-dG CLAN Ki-67 PHO 1,3 A1, BH3 Domain clAP 1-2 Klotho PKA, PKB, PKC Acinus C-Myc Kos1 Plakoglobin Activating Transcription Factor 1-6 Cohesin, Scc1-subunit Livin Plakophilin 1, 2 AKT 1-3 Cullin 1-3 MADD Polymerase beta Anaphase Promoting Complex 2, 11 CXCR4 / Fusin Malondialdehyde/MDA Post Meiotic Segregation Increased 2 Annexin II, monomer Cyclic AMP MAP Kinase PPM1D / WIP1 Annexin VI, p70 Cyclic GMP MAP Kinase Phosphatase X Prohibitin Apaf-1 Cyclin A, B, C, D, E, G, T MAP1 Proliferating Cell Nuclear Ag APE / Ref-1 Cyclin cdc2, 4, 5 MAP126 Prostate Apoptosis Response-4 Apoptosis Inducing Factor Cytochrome B, C MAP2a,b Protein Kinase Type II ARC (Apoptosis repressor with Cytotoxic Eff. T Cells mBad, phospho PROX1 CARD) D4-GDI Mcl-1 Proximal sequence element 1/Ku Ask1 / MAPKKK5 DAP-3, DAP-5 MEK6 Prot. ATM DATF1 MEKK5 PUMA ATPase p97 DcR 1-3 Microphthalmia Rad9, BH3 Domain Aurora 2 (STK15), A, B, C DIABLO Miotic Kinesin-Like Protein-1 Raf-1 Aven DMC-1 Mitotic Proteins RAIDD AXUD1 DNA Monopolin RANK Bad, BH3 Domain DNA Fragmentation Factor 45 MSF Retinoblasma BAG-1 DNA Polymerase NBL1 Ribonucleoprotein Bak DP-1, DP-2 NFkB RNA Polymerase II BARD1 DR 3-6 NF-Y ROC Basic Ig-like variable motif-containing Drp-1 NIP1, BH3 Domain Separase Bax E2F-1, 3, 4, 6 NIP3, BH3 Domain SIRT2 Bcl-2, 2a, 6, 10, G, X, w, XL E2F 1-5 Transcription Factor NME6, N-term Smad 3, 4 Beclin 1 E47 Nod1 (Apaf-1 like protein/CARD4) SODD (Silencer of Death Domain) BID Endostatin Noxa, BH3 Domain Sodium Iodide Symporter (hNIS) Bik, BH3 Domain EphA3 (Hek) NTAL Son of Sevenless-1 (SOS-1) Bim FADD Nuclear Ag of proliferating cells STAT1 BIRC 1-8 FAP-1 NuMA Superoxide Dismutase Immunologicals Bmf, BH3 Domain FAS OAS 1, 3 Survivin BNIP3L, BH3 Domain FAS Ligand p/CIP/p300 TACE / ADAM17 Bok, BH3 Domain Fen-1 p14ARF TACI Bonzo / STRL33 / TYMSTR Fodrin-alpha (spectrin-alpha) p15INK4b TATA binding protein BPDE FosB p16 TdT BPDE DNA FOXO1a p16INK4a TIA-1 BRAF35 FPG p18INK4c TID-1 BRCA 1-2 Fra 2 p19ARF Topoisomerase II alpha Bromodeoxyuridine G protein p19Skp1 TR2 BTF / BCLAF1, Abvanced panel GADD 45 p21WAF1 TRADD A.4 CAS Glutamylcysteine Synthetase gamma p27 TRAF 2, 5 Caspase 1-10 Glyceraldehyde-3-PDH p27Kip1 TRAIL / Apo2L Catenin beta Glycogen Synthetase Kinase 3 beta p35nck5a TRANCE / RANKL CD95 / Fas Granzyme B p53 Transcription Factor IIB CDC2 GRIM-19 p57 Tri-Methyl Guanosine Cap CDC6 GTPase Activating Protein p63 TROY / TAJ CDC7 Phosphatase H2AX, phosphorylated p73 USF1 CDC14A Phosphatase HEC1 p95 /NBS1 USP7 CDC25a ,b, c Histones p95VAV UVssDNA CDC34 Holocytochrome c p107 Vasoactive Intestinal Peptide Receptor CDC37 HOX-11 p130 2 CDC47 Hrk, BH3 domain PAPK VDR CDh1 HSTK12 PAR 4 VEGF CDK 1-11 ICAD (DFF45) PAR polymer Vitamin D Receptor (VDR) CENP-F Iceberg PARP WISP 1, 2 C-Ets-1 I-FLICE / CASPER PBR Wnt-1 C-Fos IkB PCNA WT1 CIDE-3 IPAF or CARD12 PCTAIRE2 XIAP CIDE-A , B Jo-1 Antigen Perforin X-linked inhibitor of Apoptosis XPF Z-DNA Tel 33 (0)4 70 03 88 55 !! Hot line 33 (0)4 70 03 73 06 Fax 33 (0)4 70 03 82 60 Primary Antibodies & Antigens
Load more

Recommended publications
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Tetraspanin CD53: an Overlooked Regulator of Immune Cell Function
    Medical Microbiology and Immunology (2020) 209:545–552 https://doi.org/10.1007/s00430-020-00677-z REVIEW Tetraspanin CD53: an overlooked regulator of immune cell function V. E. Dunlock1 Received: 31 March 2020 / Accepted: 2 May 2020 / Published online: 21 May 2020 © The Author(s) 2020 Abstract Tetraspanins are membrane organizing proteins that play a role in organizing the cell surface through the formation of subcellular domains consisting of tetraspanins and their partner proteins. These complexes are referred to as tetraspanin enriched microdomains (TEMs) or the tetraspanin web. The formation of TEMs allows for the regulation of a variety of cellular processes such as adhesion, migration, signaling, and cell fusion. Tetraspanin CD53 is a member of the tetraspanin superfamily expressed exclusively within the immune compartment. Amongst others, B cells, CD4+ T cells, CD8+ T cells, dendritic cells, macrophages, and natural killer cells have all been found to express high levels of this protein on their sur- face. Almost three decades ago it was reported that patients who lacked CD53 sufered from an increased susceptibility to pathogens resulting in the clinical manifestation of recurrent viral, bacterial, and fungal infections. This clearly suggests a vital and non-redundant role for CD53 in immune function. Yet, despite this striking fnding, the specifc functional roles of CD53 within the immune system have remained elusive. This review aims to provide a concise overview of the published literature concerning CD53 and refect on the underappreciated role of this protein in immune cell regulation and function. Keywords Tetraspanins · Tetraspanin enriched microdomains · CD53 · Membrane organization · Immune cell signaling · Immune cell adhesion Introduction: tetraspanins in the immune surface or on intracellular membranes.
    [Show full text]
  • FLRT Proteins Are Endogenous Latrophilin Ligands and Regulate Excitatory Synapse Development
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Neuron Report FLRT Proteins Are Endogenous Latrophilin Ligands and Regulate Excitatory Synapse Development Matthew L. O’Sullivan,1,5 Joris de Wit,1,5 Jeffrey N. Savas,2 Davide Comoletti,3 Stefanie Otto-Hitt,1,6 John R. Yates III,2 and Anirvan Ghosh1,4,* 1Neurobiology Section, Division of Biology, University of California San Diego, La Jolla, CA 92093, USA 2Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037, USA 3Child Health Institute of New Jersey and Department of Neuroscience and Cell Biology, UMDNJ/Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA 4CNS Discovery, F. Hoffmann-La Roche, 4070 Basel, Switzerland 5These authors contributed equally to this work 6Present address: Department of Natural Sciences, Carroll College, Helena, MT 59625, USA *Correspondence: [email protected] DOI 10.1016/j.neuron.2012.01.018 SUMMARY much effort has been expended investigating the mechanisms of a-latrotoxin action (Su¨ dhof, 2001), nothing is known about Latrophilins (LPHNs) are a small family of G protein- the endogenous function of latrophilins in vertebrates. Further coupled receptors known to mediate the massive evidence for the importance of latrophilins in the proper synaptic exocytosis caused by the black widow functioning of neural circuits comes from recent human spider venom a-latrotoxin, but their endogenous genetics studies that have linked LPHN3 mutations to attention ligands and function remain unclear. Mutations in deficit hyperactivity disorder (ADHD), a common and highly LPHN3 are strongly associated with attention deficit heritable developmental psychiatric disorder (Arcos-Burgos et al., 2010; Domene´ et al., 2011; Jain et al., 2011; Ribase´ s hyperactivity disorder, suggesting a role for latrophi- et al., 2011).
    [Show full text]
  • Edinburgh Research Explorer
    Edinburgh Research Explorer International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list Citation for published version: Davenport, AP, Alexander, SPH, Sharman, JL, Pawson, AJ, Benson, HE, Monaghan, AE, Liew, WC, Mpamhanga, CP, Bonner, TI, Neubig, RR, Pin, JP, Spedding, M & Harmar, AJ 2013, 'International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands', Pharmacological reviews, vol. 65, no. 3, pp. 967-86. https://doi.org/10.1124/pr.112.007179 Digital Object Identifier (DOI): 10.1124/pr.112.007179 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Pharmacological reviews Publisher Rights Statement: U.S. Government work not protected by U.S. copyright General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 1521-0081/65/3/967–986$25.00 http://dx.doi.org/10.1124/pr.112.007179 PHARMACOLOGICAL REVIEWS Pharmacol Rev 65:967–986, July 2013 U.S.
    [Show full text]
  • 3398 Orphan Nuclear Receptor Function in the Ovary Huajun Zhao1, Zili
    [Frontiers in Bioscience 12, 3398-3405, May 1, 2007] Orphan nuclear receptor function in the ovary Huajun Zhao1, Zili Li1, Austin J. Cooney2, Zi-Jian Lan1 1Birth Defects Center, Department of Molecular, Cellular and Craniofacial Biology, University of Louisville Health Sciences Center, Louisville, KY 40202 2Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030 TABLE OF CONTENTS 1. Abstract 2. Introduction 3. Germ Cell Nuclear Factor 4. Steroidogenic Factor-1 5. Liver Receptor Homolog-1 6. Perspective 7. Acknowledgement 8. References 1. ABSTRACT 2. INTRODUCTION Orphan nuclear receptors such as germ cell In the mammalian ovary, follicles are the nuclear factor (GCNF), steroidogenic factor 1 (SF-1) and principal functional units which provide the support system liver receptor homolog-1 (LRH-1), are emerging as necessary for production of female germ cells (mature important ovarian factors in regulating female oocytes) during postnatal life (1). The process of follicular reproduction. Within the ovary, GCNF (NR6A1) development after birth is termed folliculogenesis and the expression is restricted to the oocyte, while SF-1 (NR5A1) production of fertilizable eggs is referred to as oogenesis. is expressed only in the somatic cells, such as granulosa, During reproductive life, folliculogenesis and oogenesis are thecal and luteal cells, and interstitial cells. LRH-1 highly coordinated to ensure the production of fertilizable (NR5A2), an orphan receptor closely related to SF-1, is eggs. These processes require intercellular communication expressed only in the granulosa cells of the follicles and between many cell types such as oocytes, granulosa and luteal cells within the ovary. Recent studies using thecal cells within the ovary (2, 3).
    [Show full text]
  • Expression of the Tetraspanins CD9, CD37, CD63, and CD151 in Merkel Cell Carcinoma: Strong Evidence for a Posttranscriptional Fine-Tuning of CD9 Gene Expression
    Modern Pathology (2010) 23, 751–762 & 2010 USCAP, Inc. All rights reserved 0893-3952/10 $32.00 751 Expression of the tetraspanins CD9, CD37, CD63, and CD151 in Merkel cell carcinoma: strong evidence for a posttranscriptional fine-tuning of CD9 gene expression Markus Woegerbauer1, Dietmar Thurnher1, Roland Houben2, Johannes Pammer3, Philipp Kloimstein1, Gregor Heiduschka1, Peter Petzelbauer4 and Boban M Erovic1 1Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna, Austria; 2Department of Dermatology, Medical University of Wuerzburg, Germany; 3Department of Clinical Pathology, Medical University of Vienna, Vienna, Austria and 4Department of Dermatology, Medical University of Vienna, Vienna, Austria Tetraspanins including CD9, CD37, CD63, and CD151 are linked to cellular adhesion, cell differentiation, migration, carcinogenesis, and tumor progression. The aim of the study was to detect, quantify, and evaluate the prognostic value of these tetraspanins in Merkel cell carcinoma and to study the regulation of CD9 mRNA expression in Merkel cell carcinoma cell lines in detail. Immunohistochemical staining of 28 Merkel cell carcinoma specimens from 25 patients showed a significant correlation of CD9 (P ¼ 0.03) and CD151 (P ¼ 0.043) expression to overall survival. CD9 and CD63 expression correlated significantly to patients’ disease-free interval (P ¼ 0.017 and P ¼ 0.058). Of primary Merkel cell carcinoma tumors, 42% were CD9 positive in contrast to only 21% of the subcutaneous in-transit metastases. Characterization of the 50 untranslated region (UTR) of the CD9 mRNA from two cultured Merkel cell carcinoma cell lines revealed the presence of two major RNA species differing only in the length of their 50 termini (183 versus 102 nucleotides).
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Human Eosinophils and Their Activation by Allergens Via Danger
    Human eosinophils and their activation by allergens via danger signal receptors Elin Redvall ______________________ 2010 Department of Infectious diseases, Institute of Biomedicine, The Sahlgrenska Academy Cover illustration photo: Kerstin Andersson (Eosinophils) Abstract Human eosinophilic granulocytes are polymorphonuclear cells with a powerful arsenal of cytotoxic substances in their granules, which are mainly found in the gastrointestinal mucosa, and the respiratory and genitourinary tracts. Their physiological role is incompletely understood, although it is likely they protect the mucosal surfaces, perhaps by recognizing danger signals present on microorganisms or released from damaged tissue. We have earlier shown that eosinophils can recognize and become directly activated by aeroallergens such as house dust mite (HDM) and birch pollen. Eosinophils exposed to (HDM) release both of the cytotoxic granule proteins eosinophil peroxidase (EPO) and major basic protein, whereas birch pollen extract only triggers EPO release. Here we further investigate which receptors on eosinophils are used to signal the presence of HDM and birch pollen. Recognition was found to be mediated by the formyl peptide receptors (FPRs) FPR1 and FPR2. We also characterized the expression of this family of receptors in human eosinophils and found that they express FPR1 and FPR2, but not FPR3, similar to neutrophilic granulocytes. We also discovered that signaling through FPR1 can desensitize the eotaxin-1 receptor CCR3 rendering the cells anergic with respect to chemotaxis in response to eotaxin-1, but not regarding respiratory burst. Hence, there is cross- talk between these two receptors regarding one important effector function of eosinophils. Eosinophilic reactivity in vitro to the aeroallergens HDM, birch pollen, timothy grass pollen and cat dander did not differ between individuals with allergy and healthy individuals.
    [Show full text]
  • Tetraspanin CD151 Plays a Key Role in Skin Squamous Cell Carcinoma
    Oncogene (2013) 32, 1772–1783 & 2013 Macmillan Publishers Limited All rights reserved 0950-9232/13 www.nature.com/onc ORIGINAL ARTICLE Tetraspanin CD151 plays a key role in skin squamous cell carcinoma QLi1, XH Yang2,FXu1, C Sharma1, H-X Wang1, K Knoblich1, I Rabinovitz3, SR Granter4 and ME Hemler1 Here we provide the first evidence that tetraspanin CD151 can support de novo carcinogenesis. During two-stage mouse skin chemical carcinogenesis, CD151 reduces tumor lag time and increases incidence, multiplicity, size and progression to malignant squamous cell carcinoma (SCC), while supporting both cell survival during tumor initiation and cell proliferation during the promotion phase. In human skin SCC, CD151 expression is selectively elevated compared with other skin cancer types. CD151 support of keratinocyte survival and proliferation may depend on activation of transcription factor STAT3 (signal transducers and activators of transcription), a regulator of cell proliferation and apoptosis. CD151 also supports protein kinase C (PKC)a–a6b4 integrin association and PKC-dependent b4 S1424 phosphorylation, while regulating a6b4 distribution. CD151–PKCa effects on integrin b4 phosphorylation and subcellular localization are consistent with epithelial disruption to a less polarized, more invasive state. CD151 ablation, while minimally affecting normal cell and normal mouse functions, markedly sensitized mouse skin and epidermoid cells to chemicals/drugs including 7,12-dimethylbenz[a]anthracene (mutagen) and camptothecin (topoisomerase inhibitor), as well as to agents targeting epidermal growth factor receptor, PKC, Jak2/Tyk2 and STAT3. Hence, CD151 ‘co-targeting’ may be therapeutically beneficial. These findings not only support CD151 as a potential tumor target, but also should apply to other cancers utilizing CD151/laminin-binding integrin complexes.
    [Show full text]
  • Combination Immunotherapy with Anti-CD20 and Anti-HLA-DR Monoclonal Antibodies Induces Synergistic Anti-Lymphoma Effects in Human Lymphoma Cell Lines
    UC Davis UC Davis Previously Published Works Title Combination immunotherapy with anti-CD20 and anti-HLA-DR monoclonal antibodies induces synergistic anti-lymphoma effects in human lymphoma cell lines Permalink https://escholarship.org/uc/item/8pk1f4nx Journal Leukemia & Lymphoma, 48(5) ISSN 1042-8194 Authors Tobin, Evan Denardo, Gerald Zhang, Nan et al. Publication Date 2007-05-01 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Rituximab & ChLym-1 Combined Immunotherapy Combination Immunotherapy with Anti-CD20 and Anti-HLA-DR Monoclonal Antibodies Induces Synergistic Anti-lymphoma Effects in Human Lymphoma Cell Lines Evan Tobin1, Gerald DeNardo1, Nan Zhang2, Alan L. Epstein2, Cathy Liu1 & Sally DeNardo1 1 Department of Internal Medicine, University of California Davis, CA, USA 2 Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA Running Title: Rituximab & ChLym-1 Combined Immunotherapy Keywords: Lymphoma; immunotherapy; rituximab; Lym-1; CD20; HLA-DR 1Address for correspondence: Gerald L. DeNardo, M.D. Division of Hematology and Oncology 1508 Alhambra Blvd., No. 3100 Sacramento, CA 95816 Telephone (916) 734-3787 Fax (916) 703-5014 E-mail: [email protected] 1 Rituximab & ChLym-1 Combined Immunotherapy ABSTRACT Rituximab is effective in about one half of patients with indolent lymphoma. Even these patients relapse and develop rituximab resistance. To increase potency and circumvent resistance, the anti-lymphoma effects of rituximab, an anti-CD20 MAb1, combined with chLym-12, an anti- HLA-DR MAb, were assessed in human lymphoma cell lines by examining growth inhibition and cell death, apoptosis induction, ADCC3 and CDC4. There were additive effects in all assays and synergism in cell lines, such as B35M, which displayed resistance to either MAb alone.
    [Show full text]
  • Novel CD37, Humanized CD37 and Bi-Specific Humanized CD37-CD19
    cancers Article Novel CD37, Humanized CD37 and Bi-Specific Humanized CD37-CD19 CAR-T Cells Specifically Target Lymphoma Vita Golubovskaya 1,*, Hua Zhou 1, Feng Li 1,2, Michael Valentine 1, Jinying Sun 1, Robert Berahovich 1, Shirley Xu 1, Milton Quintanilla 1, Man Cheong Ma 1, John Sienkiewicz 1, Yanwei Huang 1 and Lijun Wu 1,3,* 1 Promab Biotechnologies, 2600 Hilltop Drive, Richmond, CA 94806, USA; [email protected] (H.Z.); [email protected] (F.L.); [email protected] (M.V.); [email protected] (J.S.); [email protected] (R.B.); [email protected] (S.X.); [email protected] (M.Q.); [email protected] (M.C.M.); [email protected] (J.S.); [email protected] (Y.H.) 2 Biology and Environmental Science College, Hunan University of Arts and Science, Changde 415000, China 3 Forevertek Biotechnology, Janshan Road, Changsha Hi-Tech Industrial Development Zone, Changsha 410205, China * Correspondence: [email protected] (V.G.); [email protected] (L.W.); Tel.: +510-974-0697 (V.G.) Simple Summary: Chimeric antigen receptor (CAR) T cell therapy represents a major advancement in cancer treatment. Recently, FDA approved CAR-T cells directed against the CD19 protein for treatment of leukemia and lymphoma. In spite of impressive clinical responses with CD19-CAR-T cells, some patients demonstrate disease relapse due to either antigen loss, cancer heterogeneity or other mechanisms. Novel CAR-T cells and targets are important for the field. This report describes Citation: Golubovskaya, V.; Zhou, novel CD37, humanized CD37 and bispecific humanized CD37-CD19-CAR-T cells targeting both H.; Li, F.; Valentine, M.; Sun, J.; CD37 and CD19.
    [Show full text]
  • CD20 (B9E9): Sc-9984
    SAN TA C RUZ BI OTEC HNOL OG Y, INC . CD20 (B9E9): sc-9984 BACKGROUND APPLICATIONS CD20 is a leukocyte surface antigen consisting of four transmembrane regions CD20 (B9E9) is recommended for detection of CD20 of human origin by and cytoplasmic N- and C-termini. The cytoplasmic domain of CD20 contains Western Blotting (starting dilution 1:200, dilution range 1:100-1:1000), multiple phosphorylation sites, leading to additional isoforms. CD20 is ex- immunoprecipitation [1-2 µg per 100-500 µg of total protein (1 ml of cell pressed primarily on B cells but has also been detected on both normal and lysate)] and flow cytometry (1 µg per 1 x 10 6 cells). neoplastic T cells. CD20 functions as a calcium-permeable cation channel, and Suitable for use as control antibody for CD20 siRNA (h): sc-29972, CD20 it is known to accelerate the G to G progression induced by IGF-1. CD20 is 0 1 shRNA Plasmid (h): sc-29972-SH and CD20 shRNA (h) Lentiviral Particles: activated by the IGF-1 receptor via the subunits of the heterotrimeric G α sc-29972-V. proteins. Activation of CD20 significantly increases DNA synthesis and is thought to involve basic helix-loop-helix leucine zipper transcription factors. Molecular Weight of CD20 isoforms: 33-37 kDa. REFERENCES RECOMMENDED SECONDARY REAGENTS 1. Tedder, T.F., et al. 1994. CD20: a regulator of cell-cycle progression of B To ensure optimal results, the following support (secondary) reagents are lymphocytes. Immunol. Today 15: 450-454. recommended: 1) Western Blotting: use goat anti-mouse IgG-HRP: sc-2005 (dilution range: 1:2000-1:32,000) or Cruz Marker™ compatible goat anti- 2.
    [Show full text]